Open access
317
Views
4
CrossRef citations to date
0
Altmetric
Clinical Trial Report
Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
Janet DuBois1 DermResearch, Inc., Austin, TX, USAView further author information
, Suzanne Bruce2 Suzanne Bruce and Associates, PA, Houston, TX, USAView further author information
, Daniel Stewart3 Midwest Center for Dermatology & Cosmetic Surgery, Clinton Township, MI, USAView further author information
, Steven Kempers4 Associated Skin Care Specialists, Fridley, MN, USAView further author information
, Christy Harutunian5 Allergan Aesthetics, an AbbVie Company, Irvine, CA, USAView further author information
, Terry Boodhoo5 Allergan Aesthetics, an AbbVie Company, Irvine, CA, USAView further author information
, Amy Weitzenfeld6 Allergan Aesthetics, an AbbVie Company, Madison, NJ, USAView further author information
& Joan-En Chang-Lin5 Allergan Aesthetics, an AbbVie Company, Irvine, CA, USACorrespondence[email protected]
View further author information
show allView further author information
Pages 1507-1517
|
Published online: 15 Oct 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.